We are live on ! Find out more
TSW

Thompson Siegel & Walmsley Portfolio holdings

AUM $5.7B
1-Year Est. Return 6.69%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$6.19B
AUM Growth
+$410M
Cap. Flow
-$185M
Cap. Flow %
-2.99%
Top 10 Hldgs %
16.93%
Holding
589
New
29
Increased
115
Reduced
212
Closed
30

Top Sells

Rank Stock Value
1
Y
Alleghany Corp
Y
+$125M
2
ACGL icon
Arch Capital
ACGL
+$39.1M
3
DVN icon
Devon Energy
DVN
+$35.2M
4
ROST icon
Ross Stores
ROST
+$34.2M
5
SSNC icon
SS&C Technologies
SSNC
+$27M

Sector Composition

Rank Sector Weight
1 Financials 14.3%
2 Healthcare 10.74%
3 Communication Services 10.71%
4 Technology 10.54%
5 Industrials 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLF icon
76
Cleveland-Cliffs
CLF
$6.57B
$26.5M 0.43%
1,641,982
-422,996
-20% -$6.37M
EQT icon
77
EQT Corp
EQT
$33.3B
$25.7M 0.42%
760,071
+146,309
+24% +$5.87M
PFE icon
78
Pfizer
PFE
$143B
$24.3M 0.39%
474,633
-3,776
-0.8% -$181K
BRK.B icon
79
Berkshire Hathaway Class B
BRK.B
$1.1T
$23.2M 0.37%
74,966
-4,306
-5% -$1.28M
SPB icon
80
Spectrum Brands
SPB
$2.04B
$22.5M 0.36%
368,684
-27,468
-7% -$1.38M
GHC icon
81
Graham Holdings Company
GHC
$5.1B
$20.9M 0.34%
34,586
-1,561
-4% -$952K
ATSG
82
DELISTED
Air Transport Services Group
ATSG
$20.7M 0.33%
795,022
+133,218
+20% +$3.67M
OGN icon
83
Organon & Co
OGN
$3.56B
$20.3M 0.33%
725,018
-689,967
-49% -$17.6M
CNNE icon
84
Cannae Holdings
CNNE
$639M
$20.1M 0.32%
973,847
+12,431
+1% +$272K
CVS icon
85
CVS Health
CVS
$133B
$20.1M 0.32%
215,641
+24,222
+13% +$2.34M
MSFT icon
86
Microsoft
MSFT
$3.45T
$19.2M 0.31%
80,028
-509
-0.6% -$122K
SCHW
87
Charles Schwab
SCHW
$183B
$19M 0.31%
228,743
+54,507
+31% +$4.23M
CI icon
88
Cigna
CI
$73.7B
$19M 0.31%
57,352
-9,179
-14% -$2.9M
JNJ icon
89
Johnson & Johnson
JNJ
$618B
$19M 0.31%
107,473
-943
-0.9% -$163K
VOO icon
90
Vanguard S&P 500 ETF
VOO
$979B
$18.3M 0.3%
52,209
-139
-0.3% -$49.1K
MCK icon
91
McKesson
MCK
$100B
$18.1M 0.29%
48,210
-2,377
-5% -$887K
CVX icon
92
Chevron
CVX
$392B
$18M 0.29%
100,218
-67
-0.1% -$11.7K
SPY icon
93
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$17.7M 0.29%
46,218
-907
-2% -$349K
VZ icon
94
Verizon
VZ
$195B
$17.4M 0.28%
440,583
-14,737
-3% -$555K
CMP icon
95
Compass Minerals
CMP
$1.23B
$17.4M 0.28%
423,214
-38,410
-8% -$1.59M
BAC icon
96
Bank of America
BAC
$435B
$16.9M 0.27%
510,694
-9,298
-2% -$320K
ANIP icon
97
ANI Pharmaceuticals
ANIP
$1.8B
$16.7M 0.27%
415,280
-682
-0.2% -$25.6K
FLG
98
Flagstar Bank National Association
FLG
$5.93B
$16.6M 0.27%
644,835
+25,207
+4% +$675K
IWS icon
99
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$16.6M 0.27%
157,600
+70,062
+80% +$7.35M
REYN icon
100
Reynolds Consumer Products
REYN
$5.26B
$16.5M 0.27%
551,377
-107,902
-16% -$3.24M

Similar funds

Thompson Siegel & Walmsley's Q4 2022 Portfolio in Review

As of Q4 2022, Thompson Siegel & Walmsley held 589 positions worth $6.19B, up 7.1% from $5.78B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Thompson Siegel & Walmsley's Q4 2022 filing shows 29 new, 115 increased, 212 reduced and 30 closed positions. Its largest new stake was Exelon: 969,267 shares worth $41.9M. The largest sale was Alleghany Corp, an estimated $125M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 17% a quarter earlier, followed by Healthcare and Communication Services.

  • Thompson Siegel & Walmsley's largest Q4 2022 buy was Exelon: 969,267 shares worth $41.9M.
  • Thompson Siegel & Walmsley added most to Bio-Rad Laboratories Class A in Q4 2022, an estimated $73.6M increase.
  • Thompson Siegel & Walmsley's biggest Q4 2022 reduction was Arch Capital, cutting an estimated $39.1M.
  • Thompson Siegel & Walmsley fully exited Alleghany Corp in Q4 2022, selling an estimated $125M.
  • Thompson Siegel & Walmsley's ten largest holdings make up 17% of its $6.19B portfolio in Q4 2022.
  • Thompson Siegel & Walmsley opened 29 new positions and closed 30 in Q4 2022.
  • Thompson Siegel & Walmsley's portfolio value rose 7.1% quarter-over-quarter to $6.19B.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2022, filed 10 Feb 2023.